Advertisement

Topics

Neurimmune, Ono partner to develop mAbs for neurodegenerative diseases

14:40 EST 10 Nov 2017 | Elsevier Business Intelligence

Swiss biotech Neurimmune Holdings AG is teaming up with Japanese company Ono Pharmaceutical Co. Ltd. to develop human-derived...

Original Article: Neurimmune, Ono partner to develop mAbs for neurodegenerative diseases

NEXT ARTICLE

More From BioPortfolio on "Neurimmune, Ono partner to develop mAbs for neurodegenerative diseases"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Monoclonal antibodies MAbs
Monoclonal antibodies recognise and attach to specific proteins produced by cells.  Types of monoclonal antibodies used to treat cancer cells: Block cell dividing dividing signals Transport cancer drugs or radiation to cancer cells Tr...